| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.009 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | ISOX:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |